Allergy and Immunology · Brooklyn, NY
NPI
1609851617
Since 2005
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2084 E 67th St
Brooklyn, NY, 11234
Phone (718) 444-8014
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.1M
85,819 services
Medicare patients, 2024
439
Average age 73
Drug cost, 2024
$318K
1,341 prescriptions
Company payments, 2025
$6,497
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gad Avshalomov was code J1561 (injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg), 22,961 times for 39 patients. In total Gad Avshalomov billed 85,819 services in 59 codes, and Medicare paid $2.1M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-24.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J1561 Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | Office | 22,961 | 39 | $38.45 | $883K |
| 95004 Test - Miscellaneous | Office | 11,832 | 156 | $3.52 | $42K |
| J2357 Injection, omalizumab, 5 mg | Office | 9,756 | 15 | $29.52 | $288K |
| 95165 Treatment - Miscellaneous | Office | 8,510 | 134 | $12.96 | $110K |
| 95117 Treatment - Miscellaneous | Office | 2,185 | 135 | $11.16 | $24K |
| J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 1,880 | 15 | $35.16 | $66K |
| 95044 Test - Miscellaneous | Office | 1,812 | 23 | $4.86 | $8,815 |
| 99213 Office E&M - Established | Office | 1,107 | 359 | $78.45 | $87K |
| 96366 Intravenous Infusion, Hydration | Office | 976 | 41 | $18.58 | $18K |
| 95024 Test - Miscellaneous | Office | 800 | 101 | $7.63 | $6,108 |
| 99214 Office E&M - Established | Office | 541 | 155 | $110.18 | $60K |
| 96372 Injection Administration | Office | 414 | 32 | $13.01 | $5,384 |
| 94010 Pulmonary Function Testing | Office | 392 | 147 | $24.38 | $9,557 |
| 96365 Intravenous Infusion, Hydration | Office | 380 | 43 | $58.65 | $22K |
| 99203 Office E&M - New | Office | 121 | 121 | $96.51 | $12K |
By year: 2022 $1.9M for 84,702 services; 2023 $2.0M for 88,137 services; 2024 $2.1M for 85,819 services.
Medicare prescription drug claims, 2024
In 2024, the drug Gad Avshalomov prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 156 prescriptions and refills. In total Gad Avshalomov wrote 1,341 Medicare prescriptions that cost $318K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 156 | 169 | 97 | $3,738 |
| Epinephrine Generic | 141 | 146 | 130 | $26K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 68 | 69 | 50 | $502 |
| Arnuity Ellipta Fluticasone Furoate | 58 | 72 | 16 | $19K |
| Breo Ellipta Fluticasone/Vilanterol | 58 | 60 | Under 11 | $22K |
| Azelastine Hcl Generic | 57 | 70 | 27 | $804 |
| Fluticasone Propionate Generic | 51 | 64 | 21 | $577 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 51 | 55 | 14 | $34K |
| Symbicort Budesonide/Formoterol Fumarate | 50 | 50 | 11 | $11K |
| Prednisone Generic | 49 | 49 | 42 | $84.94 |
| Levocetirizine Dihydrochloride Generic | 40 | 58 | Under 11 | $267 |
| Montelukast Sodium Generic | 38 | 52 | Under 11 | $405 |
| Clarithromycin Generic | 37 | 37 | 27 | $623 |
| Famotidine Generic | 36 | 42 | 21 | $190 |
| Mometasone Furoate Generic | 32 | 37 | 23 | $662 |
Brand drugs: - claims; generic drugs: 733 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gad Avshalomov $6,497 ($6,497 in general payments such as food, travel and fees) from 17 companies. The largest payer was Consortium of Independent Immunology Clinics, LLC with $5,000.
| Company | Payments | Amount |
|---|---|---|
| Consortium of Independent Immunology Clinics, LLC | 1 | $5,000 |
| Novartis Pharmaceuticals Corporation NVS | 11 | $263 |
| GlaxoSmithKline, LLC. GSK | 12 | $244 |
| Pfizer Inc. PFE | 13 | $244 |
| AstraZeneca Pharmaceuticals LP AZN | 9 | $188 |
| Octapharma USA, Inc. | 8 | $148 |
| Amgen Inc. AMGN | 4 | $81.33 |
| Grifols USA, LLC | 3 | $78.22 |
| Pharming Healthcare, Inc. | 3 | $68.06 |
| Genzyme Corporation SNY | 2 | $33.68 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.